ArticleJournal of molecular medicine (Berlin, Germany)2026

Temozolomide increases the generation of cell heterogeneity in ERK activity in glioma cells.

Karine Rech Begnini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.